Takeda Chases Emerging Market Sales with Brazil Buy

25.05.2012 - Takeda Pharmaceutical, Japan's top drugmaker, is to buy Brazil's Multilab for up to 540 million Brazilian reals ($265 million) in a deal highlighting global drugmakers' appetite...